Bridget E. Bunner

Array ( [id] => 6164853 [patent_doc_number] => 20110195065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'Compositions and Methods for Diagnosing and Treating Cancer' [patent_app_type] => utility [patent_app_number] => 13/010486 [patent_app_country] => US [patent_app_date] => 2011-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 35828 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20110195065.pdf [firstpage_image] =>[orig_patent_app_number] => 13010486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8606099 [patent_doc_number] => 20130011411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-10 [patent_title] => 'METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS, AND TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/520759 [patent_app_country] => US [patent_app_date] => 2011-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 71 [patent_figures_cnt] => 71 [patent_no_of_words] => 23176 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13520759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6101668 [patent_doc_number] => 20110165160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'NEUTROKINE-ALPHA AND NEUTROKINE-ALPHA SPLICE VARIANT' [patent_app_type] => utility [patent_app_number] => 12/965535 [patent_app_country] => US [patent_app_date] => 2010-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 199558 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20110165160.pdf [firstpage_image] =>[orig_patent_app_number] => 12965535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11827693 [patent_doc_number] => 09724422 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-08 [patent_title] => 'Human lactoferrin derived peptide for use as an antigen masking agent' [patent_app_type] => utility [patent_app_number] => 13/988829 [patent_app_country] => US [patent_app_date] => 2010-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6086 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13988829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7783876 [patent_doc_number] => 20120045432 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2012-02-23 [patent_title] => 'B LYMPHOCYTE STIMULATOR ASSAYS' [patent_app_type] => utility [patent_app_number] => 12/952091 [patent_app_country] => US [patent_app_date] => 2010-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 199557 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0045/20120045432.pdf [firstpage_image] =>[orig_patent_app_number] => 12952091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7783876 [patent_doc_number] => 20120045432 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2012-02-23 [patent_title] => 'B LYMPHOCYTE STIMULATOR ASSAYS' [patent_app_type] => utility [patent_app_number] => 12/952091 [patent_app_country] => US [patent_app_date] => 2010-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 199557 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0045/20120045432.pdf [firstpage_image] =>[orig_patent_app_number] => 12952091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8074019 [patent_doc_number] => 20110240012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'RECOMBINANT HUMAN CC10 AND COMPOSITIONS THEREOF FOR USE IN THE TREATMENT OF NASAL RHINITIS' [patent_app_type] => utility [patent_app_number] => 12/945622 [patent_app_country] => US [patent_app_date] => 2010-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10007 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20110240012.pdf [firstpage_image] =>[orig_patent_app_number] => 12945622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10143339 [patent_doc_number] => 09176147 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-03 [patent_title] => 'Detection of B-cell activating factor as a biomarker for antibody mediated rejection in transplant recipients' [patent_app_type] => utility [patent_app_number] => 13/501671 [patent_app_country] => US [patent_app_date] => 2010-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 12217 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13501671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9823345 [patent_doc_number] => 08932829 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-13 [patent_title] => 'Recombinant alpha-fetoprotein and compositions thereof' [patent_app_type] => utility [patent_app_number] => 12/925513 [patent_app_country] => US [patent_app_date] => 2010-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 11992 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12925513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10856952 [patent_doc_number] => 08883145 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-11 [patent_title] => 'Methods of treatment with DLL4 antagonists and an anti-hypertensive agent' [patent_app_type] => utility [patent_app_number] => 13/501944 [patent_app_country] => US [patent_app_date] => 2010-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13624 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13501944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10169370 [patent_doc_number] => 09200071 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-01 [patent_title] => 'Methods of treating cancer using Notch1 and Notch3 antagonists' [patent_app_type] => utility [patent_app_number] => 13/498560 [patent_app_country] => US [patent_app_date] => 2010-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 41 [patent_no_of_words] => 15807 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13498560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5959529 [patent_doc_number] => 20110183916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'Apo-2 Ligand' [patent_app_type] => utility [patent_app_number] => 12/924163 [patent_app_country] => US [patent_app_date] => 2010-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 27161 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20110183916.pdf [firstpage_image] =>[orig_patent_app_number] => 12924163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8994530 [patent_doc_number] => 08518412 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-27 [patent_title] => 'Partial peptide of lacritin' [patent_app_type] => utility [patent_app_number] => 13/496437 [patent_app_country] => US [patent_app_date] => 2010-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10357 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13496437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6024918 [patent_doc_number] => 20110053244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'NOVEL PROTEIN DELIVERY SYSTEM TO GENERATE INDUCED PLURIPOTENT STEM (iPS) CELLS OR TISSUE-SPECIFIC CELLS' [patent_app_type] => utility [patent_app_number] => 12/870782 [patent_app_country] => US [patent_app_date] => 2010-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 7013 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20110053244.pdf [firstpage_image] =>[orig_patent_app_number] => 12870782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7776309 [patent_doc_number] => 20120039890 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2012-02-16 [patent_title] => 'METHODS OF TREATMENT USING ANTIBODIES TO NEUTROKINE-ALPHA' [patent_app_type] => utility [patent_app_number] => 12/870548 [patent_app_country] => US [patent_app_date] => 2010-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 162853 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0039/20120039890.pdf [firstpage_image] =>[orig_patent_app_number] => 12870548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6343342 [patent_doc_number] => 20100330073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'METHODS OF TREATMENT USING ANTIBODIES TO NEUTROKINE-ALPHA' [patent_app_type] => utility [patent_app_number] => 12/870394 [patent_app_country] => US [patent_app_date] => 2010-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 162891 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0330/20100330073.pdf [firstpage_image] =>[orig_patent_app_number] => 12870394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7776309 [patent_doc_number] => 20120039890 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2012-02-16 [patent_title] => 'METHODS OF TREATMENT USING ANTIBODIES TO NEUTROKINE-ALPHA' [patent_app_type] => utility [patent_app_number] => 12/870548 [patent_app_country] => US [patent_app_date] => 2010-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 162853 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0039/20120039890.pdf [firstpage_image] =>[orig_patent_app_number] => 12870548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8209016 [patent_doc_number] => 20120128682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'APOLIPOPROTEIN L- I VARIANTS AND THEIR USE' [patent_app_type] => utility [patent_app_number] => 13/388645 [patent_app_country] => US [patent_app_date] => 2010-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3686 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20120128682.pdf [firstpage_image] =>[orig_patent_app_number] => 13388645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8312669 [patent_doc_number] => 20120189690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'Liposomes covered with the Extracellular Domain of the APO2L/Trail Protein' [patent_app_type] => utility [patent_app_number] => 13/391582 [patent_app_country] => US [patent_app_date] => 2010-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 12733 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13391582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8689948 [patent_doc_number] => 08389475 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-05 [patent_title] => 'Relaxin analogs' [patent_app_type] => utility [patent_app_number] => 12/852373 [patent_app_country] => US [patent_app_date] => 2010-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13787 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12852373 [rel_patent_id] =>[rel_patent_doc_number] =>)